Summary.
The effect of LY326325, a novel AMPA receptor antagonist, on the conditioned avoidance response and catalepsy was investigated in the rat. The conditioned avoidance response is a behavioral methodology which is regarded to predict potential antipsychotic efficacy of experimental drugs. Catalepsy ratings were utilized to assess the putative propensity of LY325326 to induce extrapyramidal side effects. Systemic administration of LY326325, 18 mg/kg subcutaneously, caused a selective suppression of conditioned avoidance response, without effect on escape behavior or intertrial crosses. In addition, no catalepsy was observed. Our present and previous results support an antipsychotic effect of AMPA receptor antagonists with a low liability for extrapyramidal side effects, i.e. pharmacological effects consonant with an atypical antipsychotic profile.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received September 9, 1998; accepted February 17, 1999
Rights and permissions
About this article
Cite this article
Mathé, J., Fagerquist, M. & Svensson, T. Antipsychotic-like effect of the AMPA receptor antagonist LY326325 as indicated by suppression of conditioned avoidance response in the rat. J Neural Transm 106, 1003–1009 (1999). https://doi.org/10.1007/s007020050218
Issue Date:
DOI: https://doi.org/10.1007/s007020050218